A new study finds no significant differences in cardiovascular and thromboembolic risks among biologics for psoriasis or ...
In this retrospective study of patients with comorbid type 2 diabetes mellitus and tobacco use disorder (TUD), semaglutide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback